Bausch Health Companies reported $894M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Amgen USD 1.69B 4M Jun/2025
ANI Pharmaceuticals USD 81.77M 5.24M Jun/2025
Aurora Cannabis CAD 45.63M 7.45M Jun/2025
Bausch Health Companies USD 894M 27M Jun/2025
Biogen USD 583.8M 11.3M Jun/2025
Bristol-Myers Squibb USD 1.71B 129M Jun/2025
Canopy Growth CAD 40.12M 504K Jun/2025
Corcept Therapeutics USD 103.85M 13.19M Jun/2025
Danaher USD 2.36B 502M Jun/2025
Drreddys Laboratories INR 23.18B 1.59B Jun/2025
Eli Lilly USD 2.75B 390.8M Jun/2025
Gilead Sciences USD 1.36B 100M Jun/2025
Novo Nordisk 18.85B 2.74B Jun/2025
Pacira USD 77.19M 9.58M Jun/2025
Perrigo USD 273.1M 8.1M Jun/2025
Prestige Brands USD 28.46M 35.6M Jun/2025
Supernus Pharmaceuticals USD 62.22M 27.72M Jun/2025
Vertex Pharmaceuticals USD 424.6M 28.2M Jun/2025
Zoetis USD 617M 54M Jun/2025